CXSL2500542 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2025-07-05 | | Betta Pharmaceuticals Co Ltd | | | view |
CXSL2400603 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-11 | | Betta Pharmaceuticals Co Ltd | | | view |
CXSL2300322 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2023-05-09 | | Betta Pharmaceuticals Co Ltd | | | view |
CXSB2200001 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | Supplementary Application | 2022-01-07 | | Betta Pharmaceuticals Co Ltd | | | view |